A comprehensive view of Sanofi SA. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Sanofi SA Champions Workplace Excellence and Advocates for Vaccination, Earning Industry Recognition and Influencing Public Health Policies
Published:
May 01, 2024
by Industry Intelligence Inc.
|
Pfizer dominates ZoomRx physician ranking of vaccine manufacturers, with a significant lead over Merck across reputation, innovation, patient and HCP centricity categories; Moderna, GSK and Sanofi round out the top five spots
Published:
May 01, 2024
by FiercePharma
|
Press Release: Annual General Meeting of April 30, 2024
Published:
April 30, 2024
by Sanofi SA
|
Sanofi to showcase new data on potential respiratory disease treatments at the American Thoracic Society International Conference in San Diego, California, May 17-22; Sanofi to present 25 abstracts across approved and investigational medicines
Published:
April 26, 2024
by Sanofi SA
|
Sanofi reports 7% year-over-year Q1 sales growth fueled by new launches, with Dupixent sales rising 24.9% YoY to €2,835M; robust performance supports its full-year guidance, despite a drop in business EPS and IFRS EPS
Published:
April 25, 2024
by Sanofi SA
|
Ask us about our Tissue & Hygiene market view